Anixa Biosciences Inc
For the period ended Oct 31, 2023. Filed Jan 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jan 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
The information required by this Item will be set forth in our Proxy Statement for the 2024 Annual Meeting of Stockholders scheduled for March 21, 2024 which such Proxy Statement will be filed with the SEC within 120 days of October 31, 2023, and will be incorporated into this Annual Report on Form 10-K by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.